🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

It's #WorldThrombosisDay! Today we shine a global spotlight on thrombosis as an urgent & growing health problem. Participate in one of our global events, post on social media & help us reduce the death and disability caused by #thrombosis. #WTDay22 #BloodClots #MedTwitter

Join this seminar onThrombosis and Cancer on World Thrombosis Day! mediaarena.eu/isa13octcat/ #WTD2022 World Thrombosis Day

Thank you 🙏🏼 for an excellent CAT seminar. #WTDay22

Our fantastic hosts for the next 2 days…

Another beautiful day of science. #expert_pe2022 Erik Klok

More acquired hemophilia after COVID (vaccination) ?

We felt it unbearable that #pregnant women with #thrombosis #pulmonaryembolism use #LMWH doses tested in elderly. We took the challenge and did a #RCT to find out. Stay tuned for more news on the Highlow study! Fionnuala Ní Áinle Marc Rodger Peter Verhamme INVENT-VTE INNOVTE

A milestone!

Labmeeting 🇧🇪⚽️🇧🇪

As the short month of February draws to a close, enjoying a final day of our cover selection at ATVB: An AHA Journal, for our study on #neutrophils in S. aureus-driven infective #endocarditis. bit.ly/3SC90uY

Very honored with this RPTH Editor's Award! Many thanks to all colleagues and participating centers for their efforts in challenging times! Thomas Vanassche Peter Verhamme UZ Leuven GZA Ziekenhuizen ZOL

Congrats to the team.

The Center for Molecular and Vascular Biology is leaving for #isth2023 meeting !!!! Our PhD students have 5 oral and 3 poster presentations 🤩🤩

Nog geen twee eeuwen geleden vormden Nederland, België en Luxemburg één staat. In 1830 viel het koninkrijk uiteen en kreeg Nederland er een nieuw buurland bij: België. Maar wat gebeurde er? In dit boek (verschijnt 19/10) wordt een reconstructie geboden van de periode 1815-1839.

Prof. Saskia Middeldorp at the BSTH presenting High-Low and Alife-2. Practice changing! Saskia Middeldorp

nature.com/articles/s4159… Not only an issue in the UK, but also in Belgium and many other countries. We desperately need dedicated programs that provide long-term #funding and targeted #support to allow trainee #clinician–#scientists to establish their careers and flourish!

📢Publication alert! #Annexa-I, the first-ever RCT of #andexanet in patients with intracranial bleeding who are using FXa inhibitors. What are your thoughts of the risk/benefit balance?

Is FXI inhibition the future of the management of cancer-associated thrombosis? Dr. Marcello Di Nisio provided an elegant review ICTHIC Potentially low risk of bleeding, less drug-drug interactions, less dependence on renal/liver for elimination. Phase 3 trials on-going! Stay

Great presentations from #andreasVerstraete & Art Schuermans at BSTH2024 meeting today ! Congrats Andreas for winning the PaulCapel price for clinical research 🎉🍾 Center for Molecular and Vascular Biology Department of Cardiovascular Sciences - KU Leuven

#Multi -Gene Panel for #Thrombophilia Testing in Venous Thromboembolism jthjournal.org/article/S1538-…